These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 22438421

  • 1. Pursuing the "Holy Grail".
    Dickfeld T.
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):167-70. PubMed ID: 22438421
    [No Abstract] [Full Text] [Related]

  • 2. Letter by Obeyesekere regarding article, "Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death".
    Obeyesekere MN.
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):e52; author reply e53. PubMed ID: 22811421
    [No Abstract] [Full Text] [Related]

  • 3. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.
    Wu KC, Gerstenblith G, Guallar E, Marine JE, Dalal D, Cheng A, Marbán E, Lima JA, Tomaselli GF, Weiss RG.
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):178-86. PubMed ID: 22267750
    [Abstract] [Full Text] [Related]

  • 4. The role of implantable cardiac defibrillators in cardiac sarcoidosis: saviour or sinner?
    Heck PM, Roberts PR.
    Europace; 2013 Mar; 15(3):309-10. PubMed ID: 23355135
    [No Abstract] [Full Text] [Related]

  • 5. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA, Deeprasertkul P, Nannapaneni N, Carayannopoulos GN.
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
    [No Abstract] [Full Text] [Related]

  • 6. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
    Cain ME.
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):115. PubMed ID: 16505838
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA.
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [Abstract] [Full Text] [Related]

  • 8. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.
    Fallavollita JA, Dare JD, Carter RL, Baldwa S, Canty JM.
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794139
    [Abstract] [Full Text] [Related]

  • 9. ICD triple counting leading to a lethal inappropriate shock.
    Korantzopoulos P, Manolis G, Manolis AG.
    J Cardiovasc Electrophysiol; 2020 Jan; 31(1):231-233. PubMed ID: 31778244
    [No Abstract] [Full Text] [Related]

  • 10. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY, Yam N, Lun KS, Chen RH, Au TW, Yung TC.
    Europace; 2018 Sep 01; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract] [Full Text] [Related]

  • 11. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA, Howes AJ, Boland P, Shen XS, Stuckless S, Young TL, Curtis F, Collier A, Parfrey PS, Connors SP.
    Circ Arrhythm Electrophysiol; 2016 Mar 01; 9(3):. PubMed ID: 26966288
    [Abstract] [Full Text] [Related]

  • 12. Unusual substrate underlying Brugada syndrome and early repolarization syndrome revealed in unusual circadian and seasonal patterns.
    Schwartz BG, Kloner RA, Cannom DS.
    J Cardiovasc Electrophysiol; 2012 Jul 01; 23(7):764-5. PubMed ID: 22487225
    [No Abstract] [Full Text] [Related]

  • 13. [Primary and secondary prevention of sudden cardiac death].
    Janion M, Sadowski M, Sielski J, Janion-Sadowska A.
    Pol Arch Med Wewn; 2006 Jan 01; 115(1):65-72. PubMed ID: 17278788
    [No Abstract] [Full Text] [Related]

  • 14. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D, Ringquist S, Nickenig G, Andrié R.
    PLoS One; 2018 Jan 01; 13(3):e0194496. PubMed ID: 29566033
    [Abstract] [Full Text] [Related]

  • 15. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH.
    Circ Arrhythm Electrophysiol; 2009 Dec 01; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract] [Full Text] [Related]

  • 16. Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.
    Thavikulwat AC, Tomson TT, Knight BP, Bonow RO, Choudhury L.
    J Cardiovasc Electrophysiol; 2016 Aug 01; 27(8):953-60. PubMed ID: 27138377
    [Abstract] [Full Text] [Related]

  • 17. CMR-determined scar volume: predictive for ventricular tachycardias?
    van der Wall EE, Zeppenfeld K, Bax JJ, Siebelink HM, Schalij MJ.
    Int J Cardiovasc Imaging; 2011 Oct 01; 27(7):989-93. PubMed ID: 21061171
    [Abstract] [Full Text] [Related]

  • 18. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A, Ghidina M.
    J Cardiovasc Med (Hagerstown); 2007 May 01; 8(5):320-3. PubMed ID: 17443096
    [No Abstract] [Full Text] [Related]

  • 19. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
    Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L.
    Circulation; 2014 Jul 01; 130(1):94-125. PubMed ID: 24815500
    [No Abstract] [Full Text] [Related]

  • 20. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov 01; 25(2):1-5. PubMed ID: 21638938
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.